New study pits two asthma inhalers Head-to-Head using advanced lung imaging

NCT ID NCT07282886

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to see which of two triple-combination inhalers works better for people with moderate to severe asthma that is not well controlled. About 20 adults will try both Trimbow and Trelegy Ellipta in a crossover design, and researchers will use special MRI scans to measure how well the drugs reach different parts of the lungs. The goal is to find out if one inhaler improves lung ventilation more than the other.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Alabama at Birmingham

    RECRUITING

    Birmingham, Alabama, 35233, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact